Matt Linkewich joined SK Life Science, Inc. as a founding member of the commercial team, assuming the role of Chief Commercial Officer in 2021. With nearly three decades of experience in the emerging biotech and pharmaceutical sector, Matt spearheads the commercialization endeavors for SK Life Science.

The Commercial team Matt leads is responsible for the external promotion, distribution, and access of SKLSI’s products. Its key areas include:

• Sales and Marketing: Develops and executes sales and marketing strategies as well as omnichannel marketing campaigns to reach healthcare providers, patients, and other key stakeholders.
• Commercial Operations: Supports sales and marketing execution through data analytics and market research, CRM systems, field force enablement, fleet vehicle management, commercial field force incentive compensation planning, and performance tracking.
• Market Access & Trade: Manages pricing strategy, reimbursement planning, payer engagement, patient assistance programs and trade relations. The team ensures product availability and affordability across distribution channels and healthcare systems.

Drawing from a distinctive background, Matt has established himself as a proven leader in the field of commercialization. His areas of deep expertise include organizational design, product launch, marketing strategy, sales strategy, and pricing and reimbursement. His success is underscored by a commitment to achieving commercial excellence.

Prior to joining SK Life Science, Inc., Matt held positions at IMS Health, Zeneca Pharmaceuticals, and Ortho-McNeil Pharmaceuticals. He has supported multiple franchises and provided expertise across commercial launch, marketing strategy, and commercial operations outsourcing.

Matt earned his bachelor’s degree in marketing and management from LaSalle University.